Click here to get full coverage on Cedar fever cure? Researchers developing vaccine for severe allergies - NewsNation

Cedar fever cure? Researchers developing vaccine for severe allergies  NewsNation

Cedar fever cure? Researchers developing vaccine for severe allergies - NewsNation

Click here to get full coverage on Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story (MRNA) - Seeking Alpha

Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story (MRNA)  Seeking Alpha

Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story (MRNA) - Seeking Alpha

Click here to get full coverage on Bayer sues COVID vaccine makers over mRNA technology - Reuters

Bayer sues COVID vaccine makers over mRNA technology  Reuters

Bayer sues COVID vaccine makers over mRNA technology - Reuters

Click here to get full coverage on Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis - Stanford Medicine

Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis  Stanford Medicine

Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis - Stanford Medicine

Click here to get full coverage on The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump | Editorial - The Guardian

The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump | Editorial  The Guardian

The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump | Editorial - The Guardian

Click here to get full coverage on Restoring youth to old immune cells: mRNA therapy turns back the clock - Nature

Restoring youth to old immune cells: mRNA therapy turns back the clock  Nature

Restoring youth to old immune cells: mRNA therapy turns back the clock - Nature

Click here to get full coverage on Bayer's Monsanto sues COVID vaccine makers for alleged mRNA infringement - Australian Broadcasting Corporation

Bayer's Monsanto sues COVID vaccine makers for alleged mRNA infringement  Australian Broadcasting Corporation

Bayer's Monsanto sues COVID vaccine makers for alleged mRNA infringement - Australian Broadcasting Corporation

Click here to get full coverage on Stanford scientists uncover why mRNA COVID vaccines can trigger heart inflammation - ScienceDaily

Stanford scientists uncover why mRNA COVID vaccines can trigger heart inflammation  ScienceDaily

Stanford scientists uncover why mRNA COVID vaccines can trigger heart inflammation - ScienceDaily

Click here to get full coverage on Bayer sues multiple COVID vaccine makers in lawsuit over mRNA technology - the-independent.com

Bayer sues multiple COVID vaccine makers in lawsuit over mRNA technology  the-independent.com

Bayer sues multiple COVID vaccine makers in lawsuit over mRNA technology - the-independent.com

Click here to get full coverage on Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination - Science | AAAS

Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination  Science | AAAS

Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination - Science | AAAS

Click here to get full coverage on mRNA technology for the prevention and treatment of HIV-1 infection - Nature

mRNA technology for the prevention and treatment of HIV-1 infection  Nature

mRNA technology for the prevention and treatment of HIV-1 infection - Nature

Click here to get full coverage on $MRNA stock is up 16% today. Here's what we see in our data. - Quiver Quantitative

$MRNA stock is up 16% today. Here's what we see in our data.  Quiver Quantitative

$MRNA stock is up 16% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on IAVI builds on clinical success with three-pronged mRNA vaccine against HIV - BioXconomy

IAVI builds on clinical success with three-pronged mRNA vaccine against HIV  BioXconomy

IAVI builds on clinical success with three-pronged mRNA vaccine against HIV - BioXconomy

Click here to get full coverage on Stocks making the biggest moves midday: JPMorgan, Moderna, Boeing, Cardinal Health, Chipotle & more - CNBC

Stocks making the biggest moves midday: JPMorgan, Moderna, Boeing, Cardinal Health, Chipotle & more  CNBC

Stocks making the biggest moves midday: JPMorgan, Moderna, Boeing, Cardinal Health, Chipotle & more - CNBC

Click here to get full coverage on Moderna updates 2025 outlook and highlights pipeline progress - The Globe and Mail

Moderna updates 2025 outlook and highlights pipeline progress  The Globe and Mail

Moderna updates 2025 outlook and highlights pipeline progress - The Globe and Mail

Click here to get full coverage on Lipid Nanoparticles in mRNA Vaccines Serve as Both Delivery System and Immune Stimulant - geneonline.com

Lipid Nanoparticles in mRNA Vaccines Serve as Both Delivery System and Immune Stimulant  geneonline.com

Lipid Nanoparticles in mRNA Vaccines Serve as Both Delivery System and Immune Stimulant - geneonline.com

Click here to get full coverage on Moderna (NASDAQ:MRNA) Shares Up 7.1% - Still a Buy? - MarketBeat

Moderna (NASDAQ:MRNA) Shares Up 7.1% - Still a Buy?  MarketBeat

Moderna (NASDAQ:MRNA) Shares Up 7.1% - Still a Buy? - MarketBeat

Click here to get full coverage on Why Moderna Stock Is Dropping After Good News - Barron's

Why Moderna Stock Is Dropping After Good News  Barron's

Why Moderna Stock Is Dropping After Good News - Barron's

Click here to get full coverage on New report sounds alarm on health fallout from mRNA vaccine funding cuts - Yale School of Public Health

New report sounds alarm on health fallout from mRNA vaccine funding cuts  Yale School of Public Health

New report sounds alarm on health fallout from mRNA vaccine funding cuts - Yale School of Public Health

Click here to get full coverage on Moderna (MRNA) Shares Surge by Nearly 13% - GuruFocus

Moderna (MRNA) Shares Surge by Nearly 13%  GuruFocus

Moderna (MRNA) Shares Surge by Nearly 13% - GuruFocus

Click here to get full coverage on World-changing mRNA vaccines - Penn Medicine

World-changing mRNA vaccines  Penn Medicine

World-changing mRNA vaccines - Penn Medicine

Click here to get full coverage on Arcturus Therapeutics Maps Near-Term Milestones for CF mRNA Therapy, ARCT-810 at J.P. Morgan Conference - Yahoo Finance

Arcturus Therapeutics Maps Near-Term Milestones for CF mRNA Therapy, ARCT-810 at J.P. Morgan Conference  Yahoo Finance

Arcturus Therapeutics Maps Near-Term Milestones for CF mRNA Therapy, ARCT-810 at J.P. Morgan Conference - Yahoo Finance

Click here to get full coverage on Moderna, searching for a rebound, to seek approval of mRNA flu shot - BioPharma Dive

Moderna, searching for a rebound, to seek approval of mRNA flu shot  BioPharma Dive

Moderna, searching for a rebound, to seek approval of mRNA flu shot - BioPharma Dive

Click here to get full coverage on Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient - BioSpace

Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient  BioSpace

Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient - BioSpace

Click here to get full coverage on BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial - Nature

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial  Nature

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial - Nature

Click here to get full coverage on Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy - Nature

Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy  Nature

Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy - Nature

Click here to get full coverage on Moderna (MRNA) Is Up 14.8% After Filing Global Applications For Its mRNA Flu Vaccine mRNA-1010 - Yahoo Finance

Moderna (MRNA) Is Up 14.8% After Filing Global Applications For Its mRNA Flu Vaccine mRNA-1010  Yahoo Finance

Moderna (MRNA) Is Up 14.8% After Filing Global Applications For Its mRNA Flu Vaccine mRNA-1010 - Yahoo Finance

Click here to get full coverage on mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset - Nature

mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset  Nature

mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset - Nature

Click here to get full coverage on Paolo A. Ascierto: mRNA Cancer Vaccines and Immunotherapy – A New Era in Oncology - Oncodaily

Paolo A. Ascierto: mRNA Cancer Vaccines and Immunotherapy – A New Era in Oncology  Oncodaily

Paolo A. Ascierto: mRNA Cancer Vaccines and Immunotherapy – A New Era in Oncology - Oncodaily

Click here to get full coverage on CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate - CEPI

CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate  CEPI

CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate - CEPI

Click here to get full coverage on Answering common questions on mRNA technology - PhRMA

Answering common questions on mRNA technology  PhRMA

Answering common questions on mRNA technology - PhRMA

Click here to get full coverage on Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - New England Journal of Medicine

Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine  New England Journal of Medicine

Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - New England Journal of Medicine

Click here to get full coverage on Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability - Nature

Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability  Nature

Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability - Nature

Click here to get full coverage on Moderna (MRNA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why  Yahoo Finance

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Click here to get full coverage on ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - MD Anderson Cancer Center

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy  MD Anderson Cancer Center

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - MD Anderson Cancer Center

Click here to get full coverage on Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus - CEPI

Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus  CEPI

Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus - CEPI

Click here to get full coverage on SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade  Nature

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature

Click here to get full coverage on Dean Crowe: Why Decisions about Infectious Diseases Policy Shouldn’t Slow mRNA Cancer Research - Oncodaily

Dean Crowe: Why Decisions about Infectious Diseases Policy Shouldn’t Slow mRNA Cancer Research  Oncodaily

Dean Crowe: Why Decisions about Infectious Diseases Policy Shouldn’t Slow mRNA Cancer Research - Oncodaily

Click here to get full coverage on BioNTech’s CureVac Deal Put A Floor Under A Volatile Stock - Finimize

BioNTech’s CureVac Deal Put A Floor Under A Volatile Stock  Finimize

BioNTech’s CureVac Deal Put A Floor Under A Volatile Stock - Finimize

Click here to get full coverage on How fast mRNA degrades linked to autoimmune disease risk - UCLA

How fast mRNA degrades linked to autoimmune disease risk  UCLA

How fast mRNA degrades linked to autoimmune disease risk - UCLA

Click here to get full coverage on mRNA initiation and termination are spatially coordinated - Science | AAAS

mRNA initiation and termination are spatially coordinated  Science | AAAS

mRNA initiation and termination are spatially coordinated - Science | AAAS

Click here to get full coverage on Could COVID-19 mRNA vaccines help treat cancer? - Oncology Central

Could COVID-19 mRNA vaccines help treat cancer?  Oncology Central

Could COVID-19 mRNA vaccines help treat cancer? - Oncology Central

Click here to get full coverage on RNA stability enhancers for durable base-modified mRNA therapeutics - Nature

RNA stability enhancers for durable base-modified mRNA therapeutics  Nature

RNA stability enhancers for durable base-modified mRNA therapeutics - Nature

Click here to get full coverage on Life-saving therapies are being delayed as research funding dries up | Letter - The Guardian

Life-saving therapies are being delayed as research funding dries up | Letter  The Guardian

Life-saving therapies are being delayed as research funding dries up | Letter - The Guardian

Click here to get full coverage on mRNA COVID vaccines tied to drop in death rate for 4 years - CIDRAP

mRNA COVID vaccines tied to drop in death rate for 4 years  CIDRAP

mRNA COVID vaccines tied to drop in death rate for 4 years - CIDRAP

Click here to get full coverage on Giving mRNA vaccines a technological shot in the arm - YaleNews

Giving mRNA vaccines a technological shot in the arm  YaleNews

Giving mRNA vaccines a technological shot in the arm - YaleNews

Click here to get full coverage on News Tips: Basic Scientists at Johns Hopkins Medicine Study mRNA Technology to Develop Promising Treatments - Johns Hopkins Medicine

News Tips: Basic Scientists at Johns Hopkins Medicine Study mRNA Technology to Develop Promising Treatments  Johns Hopkins Medicine

News Tips: Basic Scientists at Johns Hopkins Medicine Study mRNA Technology to Develop Promising Treatments - Johns Hopkins Medicine

Click here to get full coverage on Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines - Nature

Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines  Nature

Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines - Nature

Click here to get full coverage on MRNA: Strong cost discipline and pipeline progress set the stage for renewed growth and profitability - TradingView — Track All Markets

MRNA: Strong cost discipline and pipeline progress set the stage for renewed growth and profitability  TradingView — Track All Markets

MRNA: Strong cost discipline and pipeline progress set the stage for renewed growth and profitability - TradingView — Track All Markets

Click here to get full coverage on Slashing of funding for mRNA vaccine development raises concern - Harvard T.H. Chan School of Public Health

Slashing of funding for mRNA vaccine development raises concern  Harvard T.H. Chan School of Public Health

Slashing of funding for mRNA vaccine development raises concern - Harvard T.H. Chan School of Public Health

Click here to get full coverage on Understanding the Impact of Federal Cuts to mRNA Vaccine Research - American Lung Association

Understanding the Impact of Federal Cuts to mRNA Vaccine Research  American Lung Association

Understanding the Impact of Federal Cuts to mRNA Vaccine Research - American Lung Association

Click here to get full coverage on Aging Weakens Immunity. An mRNA Shot Turned Back the Clock in Mice. - SingularityHub

Aging Weakens Immunity. An mRNA Shot Turned Back the Clock in Mice.  SingularityHub

Aging Weakens Immunity. An mRNA Shot Turned Back the Clock in Mice. - SingularityHub

Click here to get full coverage on HHS Abandons mRNA Vaccines, Experts Warn of Threats to U.S. Health Security - Global Biodefense

HHS Abandons mRNA Vaccines, Experts Warn of Threats to U.S. Health Security  Global Biodefense

HHS Abandons mRNA Vaccines, Experts Warn of Threats to U.S. Health Security - Global Biodefense

Click here to get full coverage on Moderna reiterates target of up to 10% revenue growth in 2026 (MRNA:NASDAQ) - Seeking Alpha

Moderna reiterates target of up to 10% revenue growth in 2026 (MRNA:NASDAQ)  Seeking Alpha

Moderna reiterates target of up to 10% revenue growth in 2026 (MRNA:NASDAQ) - Seeking Alpha

Click here to get full coverage on MRNA: Growth driven by new vaccines, global expansion, and oncology pipeline, targeting profitability by 2028 - TradingView — Track All Markets

MRNA: Growth driven by new vaccines, global expansion, and oncology pipeline, targeting profitability by 2028  TradingView — Track All Markets

MRNA: Growth driven by new vaccines, global expansion, and oncology pipeline, targeting profitability by 2028 - TradingView — Track All Markets

Click here to get full coverage on Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer - UF Health - University of Florida Health

Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer  UF Health - University of Florida Health

Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer - UF Health - University of Florida Health

Click here to get full coverage on Sinergium paves the way for Latin American mRNA vaccines with new preclinical study - CEPI

Sinergium paves the way for Latin American mRNA vaccines with new preclinical study  CEPI

Sinergium paves the way for Latin American mRNA vaccines with new preclinical study - CEPI

Click here to get full coverage on mRNA Therapeutics Market Expected to Reach US$21.4 Billion - openPR.com

mRNA Therapeutics Market Expected to Reach US$21.4 Billion  openPR.com

mRNA Therapeutics Market Expected to Reach US$21.4 Billion - openPR.com

Click here to get full coverage on mRNA COVID vaccines may be helping some cancer patients fight tumors, researchers say - PBS

mRNA COVID vaccines may be helping some cancer patients fight tumors, researchers say  PBS

mRNA COVID vaccines may be helping some cancer patients fight tumors, researchers say - PBS

Click here to get full coverage on mRNA-based SARS-CoV-2 vaccines: The intracellular aggregation of encoded spike monomers and their subunits as a cause of cardiac side effects - Frontiers

mRNA-based SARS-CoV-2 vaccines: The intracellular aggregation of encoded spike monomers and their subunits as a cause of cardiac side effects  Frontiers

mRNA-based SARS-CoV-2 vaccines: The intracellular aggregation of encoded spike monomers and their subunits as a cause of cardiac side effects - Frontiers

Click here to get full coverage on ARCT: Advancing mRNA therapies for CF and OTC with strong data, regulatory focus, and solid funding - TradingView — Track All Markets

ARCT: Advancing mRNA therapies for CF and OTC with strong data, regulatory focus, and solid funding  TradingView — Track All Markets

ARCT: Advancing mRNA therapies for CF and OTC with strong data, regulatory focus, and solid funding - TradingView — Track All Markets

Click here to get full coverage on HHS Winds Down mRNA Vaccine Development Under BARDA - HHS.gov

HHS Winds Down mRNA Vaccine Development Under BARDA  HHS.gov

HHS Winds Down mRNA Vaccine Development Under BARDA - HHS.gov

Click here to get full coverage on New NIST Research Grade Test Material to support mRNA therapeutics - National Institute of Standards and Technology (.gov)

New NIST Research Grade Test Material to support mRNA therapeutics  National Institute of Standards and Technology (.gov)

New NIST Research Grade Test Material to support mRNA therapeutics - National Institute of Standards and Technology (.gov)

Click here to get full coverage on How Cuts to mRNA Vaccine Development Will Set the U.S. Back - Johns Hopkins Bloomberg School of Public Health

How Cuts to mRNA Vaccine Development Will Set the U.S. Back  Johns Hopkins Bloomberg School of Public Health

How Cuts to mRNA Vaccine Development Will Set the U.S. Back - Johns Hopkins Bloomberg School of Public Health

Click here to get full coverage on ARCT: Advancing mRNA therapies for CF and OTC with strong data, regulatory focus, and financial stability - TradingView — Track All Markets

ARCT: Advancing mRNA therapies for CF and OTC with strong data, regulatory focus, and financial stability  TradingView — Track All Markets

ARCT: Advancing mRNA therapies for CF and OTC with strong data, regulatory focus, and financial stability - TradingView — Track All Markets

Click here to get full coverage on Chemically modified tRNA enhances the translation capacity of mRNA rich in cognate codons - Nature

Chemically modified tRNA enhances the translation capacity of mRNA rich in cognate codons  Nature

Chemically modified tRNA enhances the translation capacity of mRNA rich in cognate codons - Nature

Click here to get full coverage on mRNA Vaccines and Older Adults: What to Know - The National Council on Aging (NCOA)

mRNA Vaccines and Older Adults: What to Know  The National Council on Aging (NCOA)

MRNA

Price Chart

Key Statistics

Technicals

About MRNA

Latest News

Cedar fever cure? Researchers developing vaccine for severe allergies - NewsNation

Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story (MRNA) - Seeking Alpha

Bayer sues COVID vaccine makers over mRNA technology - Reuters

Advanced Charts

Top Gainers

Top Losers